Smalcova J, Havranek S, Pokorna E, Franek O, Huptych M, Kavalkova P, Pudil J, Rob D, Dusik M, Belohlavek J
2(nd) Department of Cardiovascular Medicine, General University Hospital in Prague, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic; Emergency Medical Service Prague, Prague, Czech Republic.
2(nd) Department of Cardiovascular Medicine, General University Hospital in Prague, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
Resuscitation. 2023 Dec;193:109993. doi: 10.1016/j.resuscitation.2023.109993. Epub 2023 Oct 6.
Refractory out-of-hospital cardiac arrest (OHCA) has a poor outcome. In patients, who cannot be rescued despite using advanced techniques like extracorporeal cardiopulmonary resuscitation (ECPR), organ donation may be considered. This study aims to evaluate, in refractory OHCA, how ECPR versus a standard-based approach allows organ donorship.
The Prague OHCA trial randomized adults with a witnessed refractory OHCA of presumed cardiac origin to either an ECPR-based or standard approach. Patients who died of brain death or those who died of primary circulatory reasons and were not candidates for cardiac transplantation or durable ventricle assist device were evaluated as potential organ donors by a transplant center. In this post-hoc analysis, the effect on organ donation rates and one-year organ survival in recipients was examined.
Out of 256 enrolled patients, 75 (29%) died prehospitally or within 1 hour after admission and 107 (42%) during the hospital stay. From a total of 24 considered donors, 21 and 3 (p = 0.01) were recruited from the ECPR vs standard approach arm, respectively. Fifteen brain-dead and none cardiac-dead subjects were ultimately accepted, 13 from the ECPR and two from the standard strategy group. A total of 36 organs were harvested. The organs were successfully transplanted into 34 recipients. All transplanted organs were fully functional, and none of the recipients died due to graft failure within the one-year period post-transplant.
The ECPR-based approach in the refractory OHCA trial is associated with increased organ donorship and an excellent outcome of transplanted organs.
ClinicalTrials.gov Identifier: NCT01511666. Registered January 19, 2012.
难治性院外心脏骤停(OHCA)预后较差。对于那些即便采用体外心肺复苏(ECPR)等先进技术仍无法挽救的患者,可考虑进行器官捐献。本研究旨在评估在难治性OHCA中,ECPR与基于标准的方法相比,如何实现器官捐献。
布拉格OHCA试验将成年目击的、推测为心脏起源的难治性OHCA患者随机分为基于ECPR的方法组或标准方法组。由移植中心将因脑死亡死亡的患者或因原发性循环原因死亡且不适合心脏移植或长期心室辅助装置的患者评估为潜在器官捐献者。在这项事后分析中,研究了对器官捐献率和接受者一年内器官存活情况的影响。
在256名登记患者中,75名(29%)在院前或入院后1小时内死亡,107名(42%)在住院期间死亡。在总共24名被考虑的捐献者中,分别从ECPR组和标准方法组招募了21名和3名(p = 0.01)。最终接受了15名脑死亡患者,无一例心脏死亡患者,13名来自ECPR组,两名来自标准策略组。共获取了36个器官。这些器官成功移植给了34名接受者。所有移植器官功能完全正常,且在移植后一年内没有接受者因移植物衰竭死亡。
难治性OHCA试验中基于ECPR的方法与器官捐献增加以及移植器官的良好结局相关。
ClinicalTrials.gov标识符:NCT01511666。于2012年1月19日注册。